Odonate Therapeutics, Inc. Net Income
Odonate Therapeutics, Inc. reported Net Income of -$14.00 million for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2021-11-10
- Odonate Therapeutics, Inc. net income (loss) attributable to parent for the quarter ending 2021-09-30 was -$14.00M.
- Odonate Therapeutics, Inc. net income (loss) attributable to parent for the quarter ending 2021-06-30 was -$22.02M.
- Odonate Therapeutics, Inc. net income (loss) attributable to parent for the quarter ending 2021-03-31 was -$33.77M.
- Odonate Therapeutics, Inc. net income (loss) attributable to parent for the quarter ending 2020-12-31 was -$32.29M.
- Odonate Therapeutics, Inc. net income (loss) attributable to parent for fiscal 2020 was -$126.35M.
- Odonate Therapeutics, Inc. net income (loss) attributable to parent for fiscal 2019 was -$111.83M.
- Odonate Therapeutics, Inc. net income (loss) attributable to parent for fiscal 2018 was -$88.96M.
- Odonate Therapeutics, Inc. net income (loss) attributable to parent for fiscal 2017 was -$32.74M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2021-09-30 | -$14.00M 10-Q · filed 2021-11-10 | -$36.01M derived: sum of 2 quarters · filed 2021-11-10 | -$69.78M 10-Q · filed 2021-11-10 | -$102.07M derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-06-30 | -$22.02M 10-Q · filed 2021-11-10 | -$55.78M 10-Q · filed 2021-07-27 | -$88.07M derived: sum of 3 quarters · filed 2021-11-10 | -$118.55M derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-03-31 | -$33.77M 10-Q · filed 2021-11-10 | -$66.05M derived: sum of 2 quarters · filed 2021-11-10 | -$96.53M derived: sum of 3 quarters · filed 2021-11-10 | -$129.96M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-12-31 | -$32.29M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | -$62.76M derived: sum of 2 quarters · filed 2021-11-10 | -$96.19M derived: sum of 3 quarters · filed 2021-11-10 | -$126.35M 10-K · filed 2021-02-23 |
| 2020-09-30 | -$30.48M 10-Q · filed 2021-11-10 | -$63.90M derived: sum of 2 quarters · filed 2021-11-10 | -$94.06M 10-Q · filed 2021-11-10 | -$121.92M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | -$33.42M 10-Q · filed 2021-11-10 | -$63.59M 10-Q · filed 2021-07-27 | -$91.44M derived: sum of 3 quarters · filed 2021-11-10 | -$118.06M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-03-31 | -$30.16M 10-Q · filed 2021-11-10 | -$58.01M derived: sum of 2 quarters · filed 2021-11-10 | -$84.64M derived: sum of 3 quarters · filed 2021-11-10 | -$113.34M derived: sum of 4 quarters · filed 2021-11-10 |
| 2019-12-31 | -$27.85M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | -$54.48M derived: sum of 2 quarters · filed 2021-02-23 | -$83.18M derived: sum of 3 quarters · filed 2021-02-23 | -$111.83M 10-K · filed 2021-02-23 |
| 2019-09-30 | -$26.63M 10-Q · filed 2020-10-28 | -$55.33M derived: sum of 2 quarters · filed 2020-10-28 | -$83.97M 10-Q · filed 2020-10-28 | -$112.74M derived: sum of 4 quarters · filed 2020-10-28 |
| 2019-06-30 | -$28.70M 10-Q · filed 2020-10-28 | -$57.35M 10-Q · filed 2020-07-30 | -$86.11M derived: sum of 3 quarters · filed 2020-10-28 | -$110.04M derived: sum of 4 quarters · filed 2020-10-28 |
| 2019-03-31 | -$28.64M 10-Q · filed 2020-10-28 | -$57.41M derived: sum of 2 quarters · filed 2020-10-28 | -$81.33M derived: sum of 3 quarters · filed 2020-10-28 | -$100.72M derived: sum of 4 quarters · filed 2020-10-28 |
| 2018-12-31 | -$28.76M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | -$52.69M derived: sum of 2 quarters · filed 2020-02-20 | -$72.08M derived: sum of 3 quarters · filed 2020-02-20 | -$88.96M 10-K · filed 2020-02-20 |
| 2018-09-30 | -$23.93M 10-Q · filed 2019-11-06 | -$43.32M derived: sum of 2 quarters · filed 2019-11-06 | -$60.20M 10-Q · filed 2019-11-06 | -$75.94M derived: sum of 4 quarters · filed 2019-11-06 |
| 2018-06-30 | -$19.39M 10-Q · filed 2019-11-06 | -$36.27M 10-Q · filed 2019-07-24 | -$52.02M derived: sum of 3 quarters · filed 2019-11-06 | -$62.39M derived: sum of 4 quarters · filed 2019-11-06 |
| 2018-03-31 | -$16.88M 10-Q · filed 2019-11-06 | -$32.63M derived: sum of 2 quarters · filed 2019-11-06 | -$43.00M derived: sum of 3 quarters · filed 2019-11-06 | -$46.90M derived: sum of 4 quarters · filed 2019-11-06 |
| 2017-12-31 | -$15.75M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | -$26.12M derived: sum of 2 quarters · filed 2019-02-22 | -$30.02M derived: sum of 3 quarters · filed 2019-02-22 | -$32.74M 10-K · filed 2019-02-22 |
| 2017-09-30 | -$10.37M 10-Q · filed 2018-10-23 | -$14.27M derived: sum of 2 quarters · filed 2018-10-23 | -$17.00M 10-Q · filed 2018-10-23 | |
| 2017-06-30 | -$3.90M 10-Q · filed 2018-07-30 | -$6.63M 10-Q · filed 2018-07-30 | ||
| 2017-03-31 | -$2.73M 10-Q · filed 2018-05-03 |